You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cytarabine

Showing 51 - 75 of 753
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 9, 2021

AML, Adult Trial in Hangzhou (QN-030a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022

Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

Recruiting
  • Acute Lymphoid Leukemia
  • +3 more
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Jul 24, 2023

AML, Adult Trial in Tianjin (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022

Minimal Residual Disease Trial in Tianjin (QN-030a, Cyclophosphamid, Fludarabine)

Recruiting
  • Minimal Residual Disease
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022

Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

Not yet recruiting
  • Relapsed/Refractory AML
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 28, 2023

AML, Adult Trial in Hangzhou (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Terminated
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • cytarabine
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 18, 2022

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Cytarabine
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 1, 2021

Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +2 more
  • (no location specified)
Mar 3, 2022

Mantle Cell Lymphoma Trial in Boston (Rituximab, Bendamustine, Cytarabine)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Boston, Massachusetts
  • +2 more
Jun 9, 2021

Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Taiyuan, Shanxi, China
    Tao Wang
Feb 9, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)

Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022

Leukemia Trial in Germany (Amsacrine, Clofarabine, Cyclophosphamide)

Active, not recruiting
  • Leukemia
  • Bielefeld, Germany
  • +13 more
May 16, 2022

Langerhans Cell Histiocytosis Trial in Beijing (Cytarabine)

Recruiting
  • Langerhans Cell Histiocytosis
  • Cytarabine
  • Beijing, China
    Peking Union Medical College Hospital
Jun 7, 2021

Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

Recruiting
  • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 13, 2022

Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 21, 2023

Leukemia Trial in Chicago, Kankakee (recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine)

Withdrawn
  • Leukemia
  • recombinant interferon alfa
  • +7 more
  • Chicago, Illinois
  • +3 more
Oct 6, 2021

CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

Recruiting
  • Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Myeloid Leukemia, MDS Trial in Worldwide (Bemcentinib, Cytarabine, Decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Iowa City, Iowa
  • +11 more
Mar 1, 2022

Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
Jun 14, 2022